The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR Asks Congress to Dedicate Arthritis Research Funding to Help Military Service Members

The ACR Asks Congress to Dedicate Arthritis Research Funding to Help Military Service Members

February 14, 2017 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In 2016, the ACR and the Arthritis Foundation teamed up to direct $20 million within the Department of Defense’s (DoD’s) Congressionally Directed Medical Research Program (CDMRP) to arthritis treatment and prevention. The CDMRP has millions of research dollars that have not been committed to specific items. In the new appropriations cycle, we are once again asking that $20 million be dedicated to finding more effective ways to treat and prevent arthritis.

You Might Also Like
  • The ACR Joins Call for Dedicated Arthritis Research Funding to Help Veterans
  • Arthritis Advocacy Spotlights the Military: Veterans, including a rheumatologist, educate lawmakers about arthritis’ impact & the need for research funding
  • The ACR’s Advocates for Arthritis Volunteers Meet with Congress
Explore This Issue
February 2017
Also By This Author
  • Coding Corner Answer

Arthritis is the leading cause of disability among U.S. military veterans and the second most common reason for medical discharges from the U.S. armed services after injuries incurred in combat. One in three veterans is diagnosed with arthritis, compared with one in five members of the general U.S. population. Important note: These statistics reflect only doctor-diagnosed arthritis and, in the culture of the armed services where pain is commonly associated with weakness, likely reflects only a fraction of the actual number of U.S. service members suffering from arthritis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

It is not surprising that arthritis affects so many in the military community. The physical demands of the job lead to high-impact injuries, creating long-term damage to joints, tissue and cartilage. Even basic training activities, such as wearing packs that weigh 100-plus lbs. or jumping from trucks with heavy gear on, can result in injuries that affect service members for the rest of their lives. When such an impact injury results in arthritis and leads to the medical discharge of a service member, it can cost the DoD up to $1 million per individual. This amount reflects the medical care for a discharged member for the rest of their life for which the DoD, and not the Veterans Affairs Administration, is responsible.

Even with epidemic-level rates of arthritis among our service members, the steep financial price to the DoD and the dramatic impact on an individual’s ability to continue to serve and their reduced quality of life, Congress has still not dedicated any funding in the DoD budget to arthritis medical research. A military research ecosystem and patient population provides a unique opportunity to conduct clinical trials, test prevention strategies and explore risk factors associated with arthritis within the closed loop of medical data kept on active duty personnel. Just $20 million in dedicated funding could result in more effective ways to treat and prevent arthritis and help these service members avoid medical discharge, improve the quality of life for our veterans and fund research that could ultimately change the lives of the one in five civilians also suffering from arthritis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, From the College Tagged With: AC&R, Advocacy, American College of Rheumatology, Arthritis, Congress, Funding, prevention, Research, TreatmentIssue: February 2017

You Might Also Like:
  • The ACR Joins Call for Dedicated Arthritis Research Funding to Help Veterans
  • Arthritis Advocacy Spotlights the Military: Veterans, including a rheumatologist, educate lawmakers about arthritis’ impact & the need for research funding
  • The ACR’s Advocates for Arthritis Volunteers Meet with Congress
  • ACR Research and Education Foundation Meets with NIAMS and AF to Discuss Funding

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)